authors
- Alcalá C
- Belenguer A
- Carratalá S
- Domínguez JA
- Pérez-Miralles FC
- Gil-Perotín S
- Gasqué R
- Cubas L
- Castillo J
- Casanova B
- Quintanilla-Bordás C
- Gascón F
- PEREZ SEMPERE, ANGEL CONSTANTINO
- Navarro L
- Carcelén-Gadea M
- Landete L
- Mallada J
- Cañizares E
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study
Academic Article
2022
- Overview
- Additional Document Info
- Otro
- Ver todos